- Home
- KRMD vs ENX Comparison
KRMD vs ENX Comparison
Compare KRMD & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- ENX
- Stock Information
- Founded
- KRMD 1980
- ENX 2002
- Country
- KRMD United States
- ENX United States
- Employees
- KRMD N/A
- ENX N/A
- Industry
- KRMD Medical/Dental Instruments
- ENX Finance/Investors Services
- Sector
- KRMD Health Care
- ENX Finance
- Exchange
- KRMD Nasdaq
- ENX Nasdaq
- Market Cap
- KRMD 145.4M
- ENX 170.1M
- IPO Year
- KRMD N/A
- ENX N/A
- Fundamental
- Price
- KRMD $3.17
- ENX $9.73
- Analyst Decision
- KRMD Strong Buy
- ENX
- Analyst Count
- KRMD 4
- ENX 0
- Target Price
- KRMD $4.13
- ENX N/A
- AVG Volume (30 Days)
- KRMD 47.2K
- ENX 25.4K
- Earning Date
- KRMD 11-13-2024
- ENX 01-01-0001
- Dividend Yield
- KRMD N/A
- ENX 3.94%
- EPS Growth
- KRMD N/A
- ENX N/A
- EPS
- KRMD N/A
- ENX 0.16
- Revenue
- KRMD $31,993,796.00
- ENX N/A
- Revenue This Year
- KRMD $15.46
- ENX N/A
- Revenue Next Year
- KRMD $17.47
- ENX N/A
- P/E Ratio
- KRMD N/A
- ENX $61.00
- Revenue Growth
- KRMD 11.57
- ENX N/A
- 52 Week Low
- KRMD $1.98
- ENX $7.84
- 52 Week High
- KRMD $3.40
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- KRMD 67.44
- ENX 55.02
- Support Level
- KRMD $2.60
- ENX $9.60
- Resistance Level
- KRMD $3.40
- ENX $9.70
- Average True Range (ATR)
- KRMD 0.23
- ENX 0.12
- MACD
- KRMD 0.05
- ENX 0.03
- Stochastic Oscillator
- KRMD 73.86
- ENX 93.94
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.